Advancing Early Neuroscience Trials Through Integrated Biomarkers & Smarter P1b Design

• How combining multimodal biomarkers can strengthen proof of mechanism for early neuroscience programs
• Approaches for designing P1b trials that capture signal in psychiatry–neurology overlap indications
• Lessons from industry on executing efficient early phase studies with limited resources
• Opportunities to accelerate CIAS, BPD, and emerging neuropsychiatric assets through unified translational frameworks

Speakers:

Pranah Kalita

Head of Clinical Development, Experimental medicine, Neuroscience & Mental health

Boehringer Ingelheim